New Delhi: PB Fintech, the father or mother firm of Policybazaar, on Tuesday accredited an investment of as much as Rs 696 crore in its wholly-owned subsidiary, PB Healthcare Providers. The investment to be made via fairness shares or compulsorily convertible desire shares is topic to shareholder approval through postal poll.
Included in January this 12 months, PB Healthcare operates in the healthcare and allied providers sector.
The Board of Administrators of PB Fintech Ltd in its assembly held on March 11, 2025, accredited an investment for an mixture quantity of as much as Rs 696 crore in PB Healthcare Providers “by means of subscribing or buying its fairness shares or Obligatory Convertible Choice Shares in the course of the monetary 12 months 2025-26”, the corporate stated in a regulatory submitting.
The investment is, nonetheless, topic to the shareholder’s approval via a postal poll and can be made together with different exterior buyers in PB Healthcare Providers, it added.
PB Fintech stated the investment will strengthen the monetary well being of the healthcare arm to satisfy its basic working bills, enhancing model consciousness, and strategic initiatives.
The investment qualifies as a associated-celebration transaction however can be executed at truthful worth as decided by a registered valuer. PB Fintech, which doesn’t have an identifiable promoter group, clarified that the transaction aligns with its strategic goals, as per the regulatory submitting.
After the proposed investment, PB Fintech will maintain as much as 33.63 per cent of PB Healthcare on a completely diluted foundation.
Moreover, PB Fintech’s board accredited a postal poll discover to hunt shareholder nod for the investment. This additionally contains participation from Chairman and CEO Yashish Dahiya, Government Vice Chairman Alok Bansal, three key managerial personnel, and different exterior buyers.
The corporate said that every one regulatory approvals required for the investment could be obtained by PB Healthcare as crucial. The transaction is predicted to be accomplished inside 90 days of receiving the required approvals.
PB Fintech is a digital monetary providers platform often known as Policybazaar and Paisabazaar.
Shares of PB Fintech rose 3.09 per cent to shut at Rs 1,469.45 apiece on the BSE.
Source link
#Fintech #board #approves #investment #healthcare #arm #HealthWorld
